Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.
about
Platelets in Pulmonary Immune Responses and Inflammatory Lung DiseasesBiomarkers in Pediatric ARDS: Future DirectionsPneumonia, thrombosis and vascular diseaseOn the origin of microparticles: From "platelet dust" to mediators of intercellular communicationTissue factor signals airway epithelial basal cell survival via coagulation and protease-activated receptor isoforms 1 and 2Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges.Circulating microparticle levels are reduced in patients with ARDS.Isolation and characterization of microparticles in sputum from cystic fibrosis patientsA phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome.Human alveolar epithelial cells attenuate pulmonary microvascular endothelial cell permeability under septic conditions.Circulating microparticles: square the circle.Production, fate and pathogenicity of plasma microparticles in murine cerebral malaria.Procoagulant, tissue factor-bearing microparticles in bronchoalveolar lavage of interstitial lung disease patients: an observational studyPathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding.High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndromeHost cell invasion by Staphylococcus aureus stimulates the shedding of microvesicles.Update on acute lung injury and critical care medicine 2009.Lectin-Based Characterization of Vascular Cell Microparticle GlycocalyxKinetics of lung tissue factor expression and procoagulant activity in bleomycin induced acute lung injury.Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory responsePlatelets in the pathogenesis of acute respiratory distress syndromeTissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo.N-Acetylcysteine Amide Protects Against Oxidative Stress-Induced Microparticle Release From Human Retinal Pigment Epithelial CellsRegulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor.Myeloid tissue factor does not modulate lung inflammation or permeability during experimental acute lung injury.Mechanical forces stimulate endothelial microparticle generation via caspase-dependent apoptosis-independent mechanismNeutrophil intercellular communication in acute lung injury. Emerging roles of microparticles and gap junctions.Alveolar macrophage-derived microvesicles mediate acute lung injury.Clinical CVVH model removes endothelium-derived microparticles from circulation.Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis airway castsAnalysis of tissue factor positive microparticles.Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndromeMicroparticles and acute lung injury.Coagulation cascade proteinases in lung injury and fibrosis.Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome.Intersectin-1s: an important regulator of cellular and molecular pathways in lung injury.The role of microparticles in chronic obstructive pulmonary diseaseTransfusion-related acute lung injury: transfusion, platelets and biological response modifiers.Microparticle of drug and nanoparticle: a biosynthetic route.Macrophage-epithelial interactions in pulmonary alveoli.
P2860
Q26739670-DC1CB399-6F58-4968-98E1-D49D091D09A6Q26744577-44E3381D-CC33-467D-93AA-B48B0FBD5D74Q26853685-9DE0EDC5-CC33-4A71-BF0B-D94081531C70Q27023547-E67BE375-E68A-4A05-9AE1-C4B6F141A8ECQ30532482-A8310650-C6F2-46E1-BA6B-6D4E713D4BC0Q33615785-F7D2F944-52C1-4445-B501-B2948C91C183Q33730684-64A63867-78CF-4730-A183-0262D6F8ED65Q34020055-7F374264-9C4B-4CD6-8D98-DAC4A7562E47Q34160584-50B3F27D-41CF-440E-B9E5-D24E6CE39D54Q34580909-1BB5A377-6F1B-493D-8F76-03629A762CC0Q34680832-F57124A8-3CB2-4897-B5B3-BA98021C8713Q35126111-8547D0A2-304E-4792-837E-43A3932C3310Q35158964-2968A16F-DDC0-4CD9-99DA-678FA566F166Q35207653-CEE0CA5A-11B4-4A20-ABCF-4CDAAECD475FQ35567262-E4B75EC9-F403-4AB4-A017-F0B65B9CAD29Q35695065-DC4E158B-2D35-4202-96EE-10ED5DF49C1BQ35716122-8E69E7D7-B31C-4ECF-BDFB-3DB57DF51642Q35746142-6DEC4E96-6E3C-4C74-914F-9804B78502A2Q35829051-DFBE5DB1-1141-4C1D-820D-0C759F669F5DQ35916851-803528E0-FF17-4E35-B936-30F980AF1B61Q36237204-7DFFA7C1-BBD6-4AF1-B5D8-31501A879215Q36438085-F1165A15-BCD7-4C6F-813C-844B17D6D981Q36531479-4FEEC42A-A980-41DA-BA77-7F59559852FFQ36549153-09507F92-47E7-4721-AF0C-8CCB0903471BQ36628191-35710865-3B67-4461-83FC-7275277AF511Q36810860-2A224A3B-D2C2-4C96-8B66-F592E0501B60Q37056464-FCA94201-4099-4926-A216-D237616F974CQ37398881-70CBA4E6-11DE-4E04-A45E-BE68BE540B15Q37610439-C30D46BD-65FE-475F-9380-796CEFEAD991Q37651516-D463B827-D47D-408D-99FB-0CF3FDB5E888Q37699798-8EEC0008-D462-42C5-8327-47C37B1B533AQ37852747-9FC814C1-1CA0-4296-BA2F-C13001E1A344Q38021265-03A63112-721F-4713-A209-112904859E7AQ38026809-345A6B72-AAAF-4386-958B-DBD271BF6F5BQ38056776-55EBBA0A-4BE0-4866-BA7F-8A5EA24FCB00Q38195159-9880EE33-BAC2-484E-BD59-3661CBEE420BQ38202635-6DF35CF1-777E-409D-861A-ED71ECC34ADEQ38725992-2516DD9E-F3BF-4127-92A6-741965D9789EQ38823688-E8A4976A-2805-42E5-A9FF-4FB644CCC19CQ38832516-61448D87-526C-4497-AD4F-AF9140C70E87
P2860
Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Procoagulant alveolar micropar ...... respiratory distress syndrome.
@en
Procoagulant alveolar micropar ...... respiratory distress syndrome.
@nl
type
label
Procoagulant alveolar micropar ...... respiratory distress syndrome.
@en
Procoagulant alveolar micropar ...... respiratory distress syndrome.
@nl
prefLabel
Procoagulant alveolar micropar ...... respiratory distress syndrome.
@en
Procoagulant alveolar micropar ...... respiratory distress syndrome.
@nl
P2860
P50
P1476
Procoagulant alveolar micropar ...... respiratory distress syndrome.
@en
P2093
Frederick R Bossert
Richard D Fremont
P2860
P304
P356
10.1152/AJPLUNG.00214.2009
P577
2009-08-21T00:00:00Z